Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77,424,733
-
Total 13F shares
-
68,967,753
-
Share change
-
-3,633,429
-
Total reported value
-
$193,022,770
-
Put/Call ratio
-
79%
-
Price per share
-
$2.80
-
Number of holders
-
161
-
Value change
-
-$21,144,446
-
Number of buys
-
70
-
Number of sells
-
121
Institutional Holders of ACCENDRA HEALTH INC/VA/ - Common Stock (ACH) as of Q4 2025
As of 31 Dec 2025,
ACCENDRA HEALTH INC/VA/ - Common Stock (ACH) was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,967,753 shares.
The largest 10 holders included
Coliseum Capital Management, LLC, VANGUARD GROUP INC, BlackRock, Inc., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, D. E. Shaw & Co., Inc., Invenomic Capital Management LP, DIMENSIONAL FUND ADVISORS LP, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and PARADIGM CAPITAL MANAGEMENT INC/NY.
This page lists
161
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.